Antimicrobial resistance is a leading mortality factor worldwide. Here, we report the discovery of clovibactin, an antibiotic isolated from uncultured soil bacteria. Clovibactin efficiently kills drug-resistant Gram-positive bacterial pathogens without detectable resistance. Using biochemical assays, solid-state nuclear magnetic resonance, and atomic force microscopy, we dissect its mode of action. Clovibactin blocks cell wall synthesis by targeting pyrophosphate of multiple essential peptidoglycan precursors (C55PP, lipid II, and lipid IIIWTA). Clovibactin uses an unusual hydrophobic interface to tightly wrap around pyrophosphate but bypasses the variable structural elements of precursors, accounting for the lack of resistance. Selective and efficient target binding is achieved by the sequestration of precursors into supramolecular fibrils that only form on bacterial membranes that contain lipid-anchored pyrophosphate groups. This potent antibiotic holds the promise of enabling the design of improved therapeutics that kill bacterial pathogens without resistance development.

An antibiotic from an uncultured bacterium binds to an immutable target / Shukla R.; Peoples A.J.; Ludwig K.C.; Maity S.; Derks M.G.N.; De Benedetti S.; Krueger A.M.; Vermeulen B.J.A.; Harbig T.; Lavore F.; Kumar R.; Honorato R.V.; Grein F.; Nieselt K.; Liu Y.; Bonvin A.M.J.J.; Baldus M.; Kubitscheck U.; Breukink E.; Achorn C.; Nitti A.; Schwalen C.J.; Spoering A.L.; Ling L.L.; Hughes D.; Lelli M.; Roos W.H.; Lewis K.; Schneider T.; Weingarth M.. - In: CELL. - ISSN 0092-8674. - STAMPA. - 186:(2023), pp. 4059-4073. [10.1016/j.cell.2023.07.038]

An antibiotic from an uncultured bacterium binds to an immutable target

Lelli M.;
2023

Abstract

Antimicrobial resistance is a leading mortality factor worldwide. Here, we report the discovery of clovibactin, an antibiotic isolated from uncultured soil bacteria. Clovibactin efficiently kills drug-resistant Gram-positive bacterial pathogens without detectable resistance. Using biochemical assays, solid-state nuclear magnetic resonance, and atomic force microscopy, we dissect its mode of action. Clovibactin blocks cell wall synthesis by targeting pyrophosphate of multiple essential peptidoglycan precursors (C55PP, lipid II, and lipid IIIWTA). Clovibactin uses an unusual hydrophobic interface to tightly wrap around pyrophosphate but bypasses the variable structural elements of precursors, accounting for the lack of resistance. Selective and efficient target binding is achieved by the sequestration of precursors into supramolecular fibrils that only form on bacterial membranes that contain lipid-anchored pyrophosphate groups. This potent antibiotic holds the promise of enabling the design of improved therapeutics that kill bacterial pathogens without resistance development.
2023
186
4059
4073
Shukla R.; Peoples A.J.; Ludwig K.C.; Maity S.; Derks M.G.N.; De Benedetti S.; Krueger A.M.; Vermeulen B.J.A.; Harbig T.; Lavore F.; Kumar R.; Honorato R.V.; Grein F.; Nieselt K.; Liu Y.; Bonvin A.M.J.J.; Baldus M.; Kubitscheck U.; Breukink E.; Achorn C.; Nitti A.; Schwalen C.J.; Spoering A.L.; Ling L.L.; Hughes D.; Lelli M.; Roos W.H.; Lewis K.; Schneider T.; Weingarth M.
File in questo prodotto:
File Dimensione Formato  
PIIS009286742300853X.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 18.1 MB
Formato Adobe PDF
18.1 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1352736
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 11
social impact